Watch the poll:
Members agree. - Improving access to genetic diagnosis is essential. There are no more urgent needs. This is worth any money," they say.
Without access to modern publicly funded molecular diagnostics, including so-called liquid biopsy today, we cannot talk about effective treatment in oncology, and modern genetic testing should be an integral part of the diagnostic and therapeutic process of cancer in adult patients as well. All the more so because next-generation sequencing (NGS) is a revolution in oncology diagnostics, making it possible to analyze up to several hundred genes simultaneously, which is particularly important for molecularly diverse cancers - such cancers of the lung, breast, ovary, pancreas, prostate or colon.<... To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].Content locked